Physician profile
Jason P Akerman
NPI 1003475914
$53,156.91
in general payments reported to CMS, 2019-2025
12 companies · $667 in 2025
The $667 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $51K · 2020: $763 · 2021: $19.21 · 2023: $529 · 2024: $211 · 2025: $667.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $851 · Food and Beverage: $556.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $850.58 |
| Food and Beverage | $556.27 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $51,021.39 | 2019-2024 | Ams 800 Artificial Urinary Sphincter |
| Procept Biorobotics Corporation | $1,000.72 | 2023-2025 | Aquabeam Robotic System, Aquabeam System |
| Coloplast Corp | $763.20 | 2020 | |
| Endo USA, INC. | $119.82 | 2024-2025 | Xiaflex, Aveed |
| Ferring Pharmaceuticals INC. | $46.74 | 2024 | Adstiladrin |
| Axonics, INC. | $43.30 | 2024 | Axonics |
| Urogen Pharma, INC. | $31.48 | 2025 | |
| Tolmar, INC. | $30.11 | 2025 | Jatenzo |
| Abbvie INC. | $29.03 | 2025 | |
| Antares Pharma, INC. | $28.51 | 2024 | Xyosted |
| Calyxo, INC. | $22.61 | 2025 | Cvac Aspiration System |
| Blue Earth Diagnostics | $20.00 | 2025 | Posluma |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jason Akerman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.